Abstract
Most of the literature on pharmacogenetics assumes that the main problems in implementing the technology will be institutional ones and that although it involves genetic testing, the ethical issues involved in pharmacogenetics are different from, even less than, ‘traditional’ genetic testing. Very little attention has been paid to how clinicians will accept this technology, their attitudes towards it and how it will affect clinical practice.This paper presents results from interviews with clinicians who are beginning to use pharmacogenetics and explores how they view the ethics of pharmacogenetic testing, its use to exclude some patients from treatment, and how this kind of testing fits into broader debates around genetics. In particular this paper examines the attitudes of breast cancer and Alzheimer’s disease specialists. The results of these interviews will be compared with the picture of pharmacogenetics painted in the published literature, as a way of rooting this somewhat speculative writing in clinical practice
Keywords No keywords specified (fix it)
Categories (categorize this paper)
DOI 10.1016/j.shpsc.2006.06.003
Options
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

PhilArchive copy


Upload a copy of this paper     Check publisher's policy     Papers currently archived: 71,410
Through your library

References found in this work BETA

The Contributions of Sociology to Medical Ethics.Robert Zussman - 2000 - Hastings Center Report 30 (1):7.

View all 10 references / Add more references

Citations of this work BETA

Add more citations

Similar books and articles

Genetic Databases and Pharmacogenetics: Introduction.Richard E. Ashcroft & Adam M. Hedgecoe - 2006 - Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences 37 (3):499-502.
Group Categories in Pharmacogenetics Research.Lisa Gannett - 2005 - Philosophy of Science 72 (5):1232-1247.
Pharmacogenetics and Uncertainty: Implications for Policy Makers.Tom Ling & Ann Raven - 2006 - Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences 37 (3):533-549.
Pharmacogenetics: The Bioethical Problem of DNA Investment Banking.Oonagh P. Corrigan & Bryn Williams-Jones - 2006 - Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences 37 (3):550-565.
The Promise of Pharmacogenetics: Assessing the Prospects for Disease and Patient Stratification.Andrew Smart & Paul Martin - 2006 - Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences 37 (3):583-601.
Context Dependence.Kent Bach - 2012 - In Manuel García-Carpintero & Max Kölbel (eds.), The Continuum Companion to the Philosophy of Language. Continuum International.
Empirical Ethics, Context-Sensitivity, and Contextualism.Albert Musschenga - 2005 - Journal of Medicine and Philosophy 30 (5):467 – 490.
Ethics and Ethicists in the Modern Context.Junren Wan - 2009 - Frontiers of Philosophy in China 4 (2):227-237.

Analytics

Added to PP index
2010-08-30

Total views
56 ( #204,916 of 2,519,874 )

Recent downloads (6 months)
5 ( #137,465 of 2,519,874 )

How can I increase my downloads?

Downloads

My notes